Teresa Cabrera

6.0k total citations · 1 hit paper
77 papers, 5.0k citations indexed

About

Teresa Cabrera is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Teresa Cabrera has authored 77 papers receiving a total of 5.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Immunology, 23 papers in Oncology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Teresa Cabrera's work include Immunotherapy and Immune Responses (61 papers), Immune Cell Function and Interaction (45 papers) and T-cell and B-cell Immunology (41 papers). Teresa Cabrera is often cited by papers focused on Immunotherapy and Immune Responses (61 papers), Immune Cell Function and Interaction (45 papers) and T-cell and B-cell Immunology (41 papers). Teresa Cabrera collaborates with scholars based in Spain, Germany and United Kingdom. Teresa Cabrera's co-authors include Federico Garrido, Francisco Ruiz‐Cabello, Peter L. Stern, Natalia Aptsiauri, Miguel Ángel López‐Nevot, Ángel Concha, Isabel Maleno, Miguel López‐Botet, Juan J. Pérez‐Villar and Ignacio Algarra and has published in prestigious journals such as International Journal of Cancer, Molecular & Cellular Proteomics and Seminars in Cancer Biology.

In The Last Decade

Teresa Cabrera

77 papers receiving 5.0k citations

Hit Papers

Implications for immunosurveillance of altered HLA class ... 1997 2026 2006 2016 1997 200 400 600

Peers

Teresa Cabrera
Bertrand Huard Switzerland
Mojgan Ahmadzadeh United States
Ryan Emerson United States
Eric R. Lutz United States
Ainhoa Arina United States
Frank Borriello United States
Wenru Song United States
Bertrand Huard Switzerland
Teresa Cabrera
Citations per year, relative to Teresa Cabrera Teresa Cabrera (= 1×) peers Bertrand Huard

Countries citing papers authored by Teresa Cabrera

Since Specialization
Citations

This map shows the geographic impact of Teresa Cabrera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Teresa Cabrera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Teresa Cabrera more than expected).

Fields of papers citing papers by Teresa Cabrera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Teresa Cabrera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Teresa Cabrera. The network helps show where Teresa Cabrera may publish in the future.

Co-authorship network of co-authors of Teresa Cabrera

This figure shows the co-authorship network connecting the top 25 collaborators of Teresa Cabrera. A scholar is included among the top collaborators of Teresa Cabrera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Teresa Cabrera. Teresa Cabrera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ferrer‐Luque, Carmen María, et al.. (2020). Cytotoxic effects of alkaline tetrasodium EDTA irrigating solutions. Journal of Oral Science. 62(3). 285–287. 4 indexed citations
2.
Santana-Codina, Naiara, Rafael Carretero, Rebeca Sanz‐Pamplona, et al.. (2013). A Transcriptome-proteome Integrated Network Identifies Endoplasmic Reticulum thiol oxidoreductase (ERp57) as a Hub that Mediates Bone Metastasis. Molecular & Cellular Proteomics. 12(8). 2111–2125. 33 indexed citations
3.
Carretero, Rafael, Ena Wang, Ana Isabel Enríquez Rodríguez, et al.. (2011). Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon‐mediated rejection genes. International Journal of Cancer. 131(2). 387–395. 69 indexed citations
4.
Aptsiauri, Natalia, Rafael Carretero, Ángel M. García‐Lora, et al.. (2008). Regressing and progressing metastatic lesions: resistance to immunotherapy is predetermined by irreversible HLA class I antigen alterations. Cancer Immunology Immunotherapy. 57(11). 1727–1733. 51 indexed citations
5.
Cabrera, Teresa, et al.. (2007). Analysis of HLA class I alterations in tumors: choosing a strategy based on known patterns of underlying molecular mechanisms. Tissue Antigens. 69(s1). 264–268. 23 indexed citations
6.
Aptsiauri, Natalia, Teresa Cabrera, Ángel M. García‐Lora, et al.. (2007). MHC Class I Antigens and Immune Surveillance in Transformed Cells. International review of cytology. 256. 139–189. 115 indexed citations
7.
Aptsiauri, Natalia, Teresa Cabrera, Graham Pawelec, et al.. (2007). International conference: progress in vaccination against cancer-2006 (PIVAC 6), Granada, Spain. Cancer Immunology Immunotherapy. 56(8). 1311–1322. 3 indexed citations
8.
Cabrera, Teresa, Miguel Ángel López‐Nevot, José J. Gaforio, Francisco Ruiz‐Cabello, & Federico Garrido. (2003). Analysis of HLA expression in human tumor tissues. Cancer Immunology Immunotherapy. 52(1). 1–9. 99 indexed citations
10.
Cabrera, Teresa, J.M. Cózar, António Garrido, et al.. (2003). HLA class I expression in bladder carcinomas. Tissue Antigens. 62(4). 324–327. 31 indexed citations
11.
Algarra, Ignacio, Teresa Cabrera, & Federico Garrido. (2000). The HLA crossroad in tumor immunology. Human Immunology. 61(1). 65–73. 121 indexed citations
12.
Maleno, Isabel, et al.. (2000). Molecular strategies to define HLA haplotype loss in microdissected tumor cells. Human Immunology. 61(10). 1001–1012. 56 indexed citations
13.
Cantón, Julia, Antonia Collado, Teresa Cabrera, et al.. (1999). Chromosome loss is the most frequent mechanism contributing to HLA haplotype loss in human tumors. International Journal of Cancer. 83(1). 91–97. 4 indexed citations
14.
Cabrera, Teresa, Antonia Collado, María Angustias Parejo Fernández, et al.. (1998). High frequency of altered HLA class I phenotypes in invasive colorectal carcinomas. Tissue Antigens. 52(2). 114–123. 92 indexed citations
15.
Benítez, Ricardo Benítez, D. Godelaine, Miguel Ángel López‐Nevot, et al.. (1998). Mutations of the β2microglobulin gene result in a lack of HLA class I molecules on melanoma cells of two patients immunized with MAGE peptides. Tissue Antigens. 52(6). 520–529. 118 indexed citations
16.
Garrido, Federico, Francisco Ruiz‐Cabello, Teresa Cabrera, et al.. (1997). Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. Immunology Today. 18(2). 89–95. 627 indexed citations breakdown →
17.
Cabrera, Teresa, María Angustias Parejo Fernández, Àngels Sierra, et al.. (1996). High frequency of altered HLA class I phenotypes in invasive breast carcinomas. Human Immunology. 50(2). 127–134. 107 indexed citations
18.
Abril, Eduardo, Ángel M. García‐Lora, Antonio Serrano, et al.. (1996). Characterization of a gastric tumor cell line defective in MHC class I inducibility by both α‐ and γ‐interferon. Tissue Antigens. 47(5). 391–398. 44 indexed citations
19.
Cabrera, Teresa, Ángel Concha, Francisco Ruiz‐Cabello, & Federico Garrido. (1991). Loss of HLA Heavy Chain and β2‐Microglobulin in HLA Negative Tumours. Scandinavian Journal of Immunology. 34(2). 147–152. 15 indexed citations
20.
Cuesta, Javier, Francisco Ruiz‐Cabello, Miguel Ángel López‐Nevot, et al.. (1990). Class II HLA Antigen Expression in Familial Polyposis Coli is Related to the Degree of Dysplasia. Immunobiology. 180(2-3). 138–148. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026